This is why monoclonals are a linear tool in an exponential fight:
- Hard to scale, esp when HCWs are in short supply, and linear relationship between patients:resources; and
- They don’t touch transmission, so exponential growth quickly outstrips treatment capacity. 1/ https://t.co/Wvl6lqlImQ— Rajeev Venkayya MD (@rvenkayya) August 26, 2021